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The existence of opioid receptors was first reported by
Terenius (1972, 1973a, b) and, soon thereafter, confirmed
by several other research groups (Pert and Snyder, 1973;
Simon et al., 1973). Since opioids occur neither in the
regular diet nor in the known metabolism of vertebrates,
the existence of an opioid receptor was an enigma, solved
by the subsequent discovery of endogenous opioids (Tere-
nius and Wahlstr6m, 1974, 1975; Terenius 1975; Hughes
et al., 1975; Pasternak et al., 1975; Teschemacher et al.,
1975; Goldstein et al., 1979). It is now known that there
are several types of opioid receptors, distinguishable by
their pharmacological response (Takemori et al., 1969;
Martin et al., 1976; Lord et al., 1977).
We have shown recently that partially purified mu-
opioid receptors can be reconstituted in an artificial bilayer
membrane, which they make electrically conducting upon
addition of endogenous or exogenous opioids (Smuda and
de Levie, 1985a, b). Here we report on single-channel
observations of such reconstituted mu-opioid receptors.
A partially purified receptor preparation was obtained
from bovine brain by solubilization with the zwitterionic
detergent 3- [(3-cholamidopropyl)dimethylammonio]- 1-
propanesulfonate (CHAPS), followed by ion exchange and
affinity chromatography, whereupon the receptor was
reconstituted in a Takagi-Montal lipid bilayer, as
described earlier (Smuda and de Levie, 1985b). The only
change in procedure was the use of a somewhat faster
operational amplifier (model 3523; Burr-Brown Corp.,
Tucson, AZ) with a feedback resistance of 1 GQ as
current-to-voltage transducer, followed by a regular
100 x postamplifier feeding directly into the analog-to-
digital converter of a minicomputer (model PDP 11-20;
Digital Equipment Corp., Maynard, MA). Data were
obtained at a 1 KHz rate, and stored in 2-s segments. The
aqueous solutions on both sides of the membrane contained
0.1 M NaCl + 0.1 M KCI + 5 mM CaCl2, buffered at pH
7.6 with 20 mM HEPES, i.e., N-2-hydroxoethyl-pipera-
zine-N'-2-ethanesulfonic acid.
Although it is, in principle, possible to observe single-
channel behavior by adding extremely small amounts of
agonists, this is a risky procedure because the preparation
occasionally contains spurious channels. To safeguard
against those, we used the following procedure.
After a lipid bilayer was formed and a potential of 100
mV applied, 10 ,ul of the partially purified protein fracton
was added to the cis compartment of the measurement cell.
No electrical current resulted from the application of the
voltage (the electrode in the trans compartment being held
at virtual ground by the current-to-voltage converter) or
the presence of the protein fraction, until DAGO was
added to the cis compartment to a concentration of 50 nM;
DAGO stands for tyrosine-D-alanine-glycine-N-methyl-
phenylalanine-glycinol. The resulting electrical current
was very noisy, see Fig. 1 a, and exhibited poorly resolved
current steps of -7-pA amplitude. We then added a large
excess of naloxone, which caused the electrical activity to
decay to zero. Fig. 1 b shows one of several records
obtained during this decay, just before the current
remained permanently at baseline level. In these final
records of electrical activity, single channels are fully
resolved. They have a conductance of about 65 pS, i.e., a
resistance of about 15 G Q , which is of the usual order of
magnitude for ion channels (Hille, 1984). The presence of
naloxone appears to increase the length of time these
channels are closed but not the single-channel conduc-
tance. The pharmacological specificity of these channels,
i.e., the fact that they open with physiological concentra-
tions of mu-agonist, and close with antagonist, clearly
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FIGURE 1 Two typical two-second segments of the current flowing in
the presence of opioid receptor and 50 nm DAGO, before a and after b the
addition of 1 mM naloxone, which, soon after curve b was recorded,
completely suppressed all channel activity. Applied voltage 0.1 V, data
rate 1 KHz.
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identifies them as mu-opioid receptors. Work to charac-
terize these receptor channels in more detail is currently in
progress.
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